Cargando…

Altered radiation responses of breast cancer cells resistant to hormonal therapy

Endocrine therapy agents (the selective estrogen receptor (ER) modulators such as tamoxifen or the selective ER down-regulators such as ICI 182,780) are key treatment regimens for hormone receptor-positive breast cancers. While these drugs are very effective in controlling ER-positive breast cancer,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luzhna, Lidiya, Lykkesfeldt, Anne E., Kovalchuk, Olga
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2014
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359324/ https://www.ncbi.nlm.nih.gov/pubmed/25682200

Ejemplares similares

Micronuclei in genotoxicity assessment: from genetics to epigenetics and beyond
por: Luzhna, Lidiya, et al.
Publicado: (2013)

High and low dose radiation effects on mammary adenocarcinoma cells – an epigenetic connection
por: Luzhna, Lidia, et al.
Publicado: (2016)

Sex Difference of Radiation Response in Occupational and Accidental Exposure
por: Narendran, Nadia, et al.
Publicado: (2019)

Mobilization of LINE-1 in irradiated mammary gland tissue may potentially contribute to low dose radiation-induced genomic instability
por: Luzhna, Lidia, et al.
Publicado: (2015)

Low dose irradiation profoundly affects transcriptome and microRNAme in rat mammary gland tissues
por: Luzhna, Lidia, et al.
Publicado: (2014)

Altered signaling in anti-estrogen-resistant human breast cancer cells
por: Lykkesfeldt, AE, et al.
Publicado: (2005)

A suppressive role of guanine nucleotide-binding protein subunit beta-4 inhibited by DNA methylation in the growth of anti-estrogen resistant breast cancer cells
por: Wang, Bo, et al.
Publicado: (2018)

Crucial Role for Early Growth Response-1 in the Transcriptional Regulation of miR-20b in Breast Cancer
por: Li, Dongping, et al.
Publicado: (2013)

Determination of HER2 phosphorylation at tyrosine 1221/1222 improves prediction of poor survival for breast cancer patients with hormone receptor-positive tumors
por: Frogne, Thomas, et al.
Publicado: (2009)

HIF2α contributes to antiestrogen resistance via positive bilateral crosstalk with EGFR in breast cancer cells
por: Alam, Muhammad Wasi, et al.
Publicado: (2016)

Integrative analysis of miRNA and gene expression reveals regulatory networks in tamoxifen-resistant breast cancer
por: Joshi, Tejal, et al.
Publicado: (2016)

Case report: Response to endocrine therapy in triple-negative breast cancer metastases with altered hormone receptors
por: Qin, Ruoyan, et al.
Publicado: (2023)

Concurrent or Sequential Hormonal and Radiation Therapy in Breast Cancer: A Literature Review
por: Cecchini, Matthew J, et al.
Publicado: (2015)

Hormones and radiation as risk factors for breast cancer
por: Beral, V
Publicado: (2006)

Activation of the Her2/neu receptor leads to antiestrogen resistance, but acquired resistance is not caused by altered ErbB expression and activation
por: Larsen, SS, et al.
Publicado: (2000)

Induction and persistence of radiation-induced DNA damage is more pronounced in young animals than in old animals
por: Hudson, Darryl, et al.
Publicado: (2011)

Differential Response to α-Oxoaldehydes in Tamoxifen Resistant MCF-7 Breast Cancer Cells
por: Nass, Norbert, et al.
Publicado: (2014)

Expression of transmembrane protein 26 (TMEM26) in breast cancer and its association with drug response
por: Nass, Norbert, et al.
Publicado: (2016)

Hormonal Therapy Resistance and Breast Cancer: Involvement of Adipocytes and Leptin
por: Delort, Laetitia, et al.
Publicado: (2019)

Hormone replacement therapy, mammographic density, and breast cancer risk: a cohort study
por: Azam, Shadi, et al.
Publicado: (2018)

DMXL2 drives epithelial to mesenchymal transition in hormonal therapy resistant breast cancer through notch hyper-activation
por: Faronato, Monica, et al.
Publicado: (2015)

In situ aromatase expression in primary tumor is associated with estrogen receptor expression but is not predictive of response to endocrine therapy in advanced breast cancer
por: Lykkesfeldt, Anne E, et al.
Publicado: (2009)

Radiation Therapy for Locally Recurrent Breast Cancer
por: Siglin, Joshua, et al.
Publicado: (2012)

Altered fractionation in radiation therapy for breast cancer in the elderly: are we moving forward?
por: Pinzi, Valentina, et al.
Publicado: (2020)

Src Drives Growth of Antiestrogen Resistant Breast Cancer Cell Lines and Is a Marker for Reduced Benefit of Tamoxifen Treatment
por: Larsen, Sarah L., et al.
Publicado: (2015)

Aurora kinase B is important for antiestrogen resistant cell growth and a potential biomarker for tamoxifen resistant breast cancer
por: Larsen, Sarah L, et al.
Publicado: (2015)

New cell culture model for aromatase inhibitor-resistant breast cancer shows sensitivity to fulvestrant treatment and cross-resistance between letrozole and exemestane
por: HOLE, STINE, et al.
Publicado: (2015)

Breast tumor response to ultrasound mediated excitation of microbubbles and radiation therapy in vivo
por: Lai, Priscilla, et al.
Publicado: (2016)

Thyroid function following radiation therapy in breast cancer patients: risk of radiation-induced hypothyroidism
por: Farshchian, Negin, et al.
Publicado: (2022)

Synuclein gamma expression enhances radiation resistance of breast cancer cells
por: Tian, Lu, et al.
Publicado: (2018)

Bruceantin targets HSP90 to overcome resistance to hormone therapy in castration-resistant prostate cancer
por: Moon, Sue Jin, et al.
Publicado: (2021)

Technique alternatives for breast radiation oncology: Conventional radiation therapy to tomotherapy
por: Fournier-Bidoz, N., et al.
Publicado: (2009)

Aminoglutethimide induced hormone suppression and response to therapy in advanced postmenopausal breast cancer.
por: Harris, A. L., et al.
Publicado: (1983)

Rapid response of breast cancer to neoadjuvant intramammary testosterone-anastrozole therapy: neoadjuvant hormone therapy in breast cancer
por: Glaser, Rebecca L., et al.
Publicado: (2014)

pS2 and response to adjuvant hormone therapy in primary breast cancer.
por: Spyratos, F., et al.
Publicado: (1994)

Anti-oestrogen resistant human breast cancer cell lines are more sensitive towards treatment with the vitamin D analogue EB1089 than parent MCF-7 cells
por: Larsen, S S, et al.
Publicado: (2001)

Endocrine Resistance in Hormone Receptor Positive Breast Cancer–From Mechanism to Therapy
por: Rani, Aradhana, et al.
Publicado: (2019)

Resistance to Resilience: Understanding Post-surgical Hormone Therapy in Breast Cancer Care
por: Kumar, Tanishq, et al.
Publicado: (2023)

The Hypoxic Microenvironment of Breast Cancer Cells Promotes Resistance in Radiation Therapy
por: Gilreath, Cordell, et al.
Publicado: (2021)

Resistance to hormone therapy in breast cancer cells promotes autophagy and EGFR signaling pathway
por: Siatis, Konstantinos E., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dusncgu5gbvbdp50rmf0cr2tvl